Dr. Bray Links

Tuesday, September 22, 2015

Drug Goes From $1 to $13.50 to now $750 a Tablet, Overnight

32 y/o hedge fund investor, Martin Shkreli, decides to profit off of a 62 y/o life-saving antibiotic previously sold by Glaxo for $1 per tablet

Specialists in infectious disease are protesting a gigantic overnight increase in the price of a 62-year-old drug that is the standard of care for treating a life-threatening parasitic infection.

The drug, called Daraprim, was acquired in August by Turing Pharmaceuticals, a start-up run by a former hedge fund manager. Turing immediately raised the price to $750 a tablet from $13.50, bringing the annual cost of treatment for some patients to hundreds of thousands of dollars.

“What is it that they are doing differently that has led to this dramatic increase?” said Dr. Judith Aberg, the chief of the division of infectious diseases at the Icahn School of Medicine at Mount Sinai. She said the price increase could force hospitals to use “alternative therapies that may not have the same efficacy.”


No comments:

Post a Comment

Note: Only a member of this blog may post a comment.